Knockdown of AGR2 expression in estrogen receptor-α-positive breast cancer cell lines inhibited cell growth and induced cell death by modulating expression of cyclin D1, estrogen receptor-α, and survivin[6]. This evidence concerns the gene ESR1 and breast carcinoma.